Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propranolol hydrochloride, quantity: 40 mg - tablet - excipient ingredients: povidone; sodium starch glycollate; lactose monohydrate; quinoline yellow; magnesium stearate; maize starch; sunset yellow fcf aluminium lake; brilliant blue fcf aluminium lake - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - propranolol hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; maize starch; povidone; sunset yellow fcf aluminium lake; magnesium stearate; quinoline yellow; sodium starch glycollate - angina pectoris; hypertension; prevention of migraine; cardiac dysrhythmias: certain intrinsic cardiac dysrhythmias; dysrhythmias associated with thyrotoxicosis; anxiety tachycardia; certain drug-induced dysrhythmias (eg tachycardia due to digitalis or adrenaline overdosage); essential tremor, including familial and senile tremor; phaeochromocytoma (only with concurrent alpha-receptor blockade); hypertrophic subaortic stenosis; suspected or definite myocardial infarction; fallot?s tetralogy

United States - English - NLM (National Library of Medicine)

pierre fabre pharmaceuticals, inc. - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride 4.28 mg in 1 ml - hemangeol oral solution contains the beta-adrenergic blocker propranolol hydrochloride and is indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy. hemangeol is contraindicated in the following conditions: - premature infants with corrected age < 5 weeks - infants weighing less than 2 kg - known hypersensitivity to propranolol or any of the excipients [see description (11)] - asthma or history of bronchospasm - heart rate <80 beats per minute, greater than first degree heart block, or decompensated heart failure - blood pressure <50/30 mmhg - pheochromocytoma of 460 infants with proliferating infantile hemangioma requiring systemic therapy who were treated with hemangeol starting at 5 weeks to 5 months of age, 60% had complete or nearly complete resolution of their hemangioma at week 24 [see  clinical studies (14)]. safety and effectiveness for infantile hemangioma have not been established in pediatric

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - injection - 1 mg in 1 ml - intravenous administration is usually reserved for life-threatening arrhythmias or those occurring under anesthesia. - supraventricular arrhythmiasintravenous propranolol is indicated for the short-term treatment of supraventricular tachycardia, including wolff-parkinson-white syndrome and thyrotoxicosis, to decrease ventricular rate. use in patients with atrial flutter or atrial fibrillation should be reserved for arrythmias unresponsive to standard therapy or when more prolonged control is required. reversion to normal sinus rhythm has occasionally been observed, predominantly in patients with sinus or atrial tachycardia.

Malta - English - Medicines Authority

central procurement & supplies unit - propranolol hydrochloride - oral solution - propranolol hydrochloride 5 milligram(s)/5 millilitre - beta blocking agents

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride tablets are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. pr

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride tablets are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. pr

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride tablets are indicated in the management of hypertension. it may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. prop

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride tablets usp are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets usp are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets usp are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets usp are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets usp are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets usp are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not in

United States - English - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - propranolol hydrochloride (unii: f8a3652h1v) (propranolol - unii:9y8nxq24vq) - propranolol hydrochloride tablets usp are indicated in the management of hypertension. they may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. propranolol hydrochloride tablets usp are not indicated in the management of hypertensive emergencies. propranolol hydrochloride tablets usp are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. propranolol hydrochloride tablets usp are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. propranolol hydrochloride tablets usp are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of myocardial infarction and are clinically stable. propranolol hydrochloride tablets usp are indicated for the prophylaxis of common migraine headache. the efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not in